[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 1840 Reported in Senate (RS)]
<DOC>
Calendar No. 317
118th CONGRESS
2d Session
S. 1840
To amend the Public Health Service Act to reauthorize and improve the
National Breast and Cervical Cancer Early Detection Program for fiscal
years 2024 through 2028, and for other purposes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
June 7, 2023
Ms. Baldwin (for herself, Ms. Collins, Ms. Cortez Masto, Mrs. Capito,
Ms. Klobuchar, and Ms. Murkowski) introduced the following bill; which
was read twice and referred to the Committee on Health, Education,
Labor, and Pensions
February 1, 2024
Reported by Mr. Sanders, with an amendment
[Strike out all after the enacting clause and insert the part printed
in italic]
_______________________________________________________________________
A BILL
To amend the Public Health Service Act to reauthorize and improve the
National Breast and Cervical Cancer Early Detection Program for fiscal
years 2024 through 2028, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
<DELETED>SECTION 1. SHORT TITLE.</DELETED>
<DELETED> This Act may be cited as the ``Screening for Communities
to Receive Early and Equitable Needed Services for Cancer Act of 2023''
or the ``SCREENS for Cancer Act of 2023''.</DELETED>
<DELETED>SEC. 2. FINDINGS.</DELETED>
<DELETED> Congress finds the following:</DELETED>
<DELETED> (1) In 2023, there will be more than 300,590 new
cases of invasive breast cancer and nearly 44,000 breast cancer
deaths in the United States.</DELETED>
<DELETED> (2) In 2023, there will be about 13,960 new cases
of invasive cervical cancer and about 4,310 deaths from
cervical cancer.</DELETED>
<DELETED> (3) Black women have the highest breast, cervical,
and uterine cancer death rates of all racial and ethnic groups
and are more likely to be diagnosed with triple-negative breast
cancer, a more aggressive form of cancer.</DELETED>
<DELETED> (4) Research shows that the COVID-19 pandemic was
associated with a decline of more than 3,900,000 breast cancer
screenings in 2020, as compared to 2019. Similarly, cervical
cancer screening utilization dropped by 90 percent in April
2020, relative to the prior year.</DELETED>
<DELETED> (5) Research suggests that those postponed breast
screenings appeared to disproportionately affect women of
color: Non-Hispanic White women had 17 percent fewer breast
cancer diagnoses, while the year-over-year decline was 53
percent for Asian women, 43 percent for Hispanic women, and 27
percent for Black women.</DELETED>
<DELETED> (6) The National Cancer Institute estimates that
pandemic-related disruptions or delays in breast care and
screening are expected to result in an excess of 2,500 breast
cancer deaths by 2030.</DELETED>
<DELETED> (7) Since its creation in 1991, the National
Breast and Cervical Cancer Early Detection Program (referred to
in this section as the ``NBCCEDP'') has provided lifesaving
cancer screening and diagnostic services to low-income,
uninsured, or underinsured women in all 50 States, the District
of Columbia, 6 territories, and 13 Tribes or Tribal
organizations.</DELETED>
<DELETED> (8) NBCCEDP seeks to reduce inequities in breast
and cervical cancer screening and diagnosis, placing special
emphasis on outreach to women who are members of racial or
ethnic minority groups, and those who are geographically or
culturally isolated.</DELETED>
<DELETED> (9) NBCCEDP has served more than 6,100,000 people
and provided more than 15,700,000 breast and cervical cancer
screening examinations.</DELETED>
<DELETED> (10) These screening exams have diagnosed nearly
76,000 invasive breast cancers and more than 24,000
premalignant breast lesions, as well as more than 5,100
invasive cervical cancers and 235,000 premalignant cervical
lesions, of which 39 percent were high-grade.</DELETED>
<DELETED> (11) The program also provides public education,
outreach, patient navigation, and care coordination to increase
breast and cervical cancer screening rates and reach
underserved populations.</DELETED>
<DELETED> (12) Reauthorizing NBCCEDP will result in expanded
services, leading to more people being screened and more
cancers diagnosed at earlier stages.</DELETED>
<DELETED>SEC. 3. NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION
PROGRAM.</DELETED>
<DELETED> Title XV of the Public Health Service Act (42 U.S.C. 300k
et seq.) is amended--</DELETED>
<DELETED> (1) in section 1501 (42 U.S.C. 300k)--</DELETED>
<DELETED> (A) in subsection (a)--</DELETED>
<DELETED> (i) in paragraph (2), by striking
``the provision of appropriate follow-up
services and support services such as case
management'' and inserting ``that appropriate
follow-up services are provided'';</DELETED>
<DELETED> (ii) in paragraph (3), by striking
``programs for the detection and control'' and
inserting ``for the prevention, detection, and
control'';</DELETED>
<DELETED> (iii) in paragraph (4), by
striking ``the detection and control'' and
inserting ``the prevention, detection, and
control'';</DELETED>
<DELETED> (iv) in paragraph (5)--</DELETED>
<DELETED> (I) by striking
``monitor'' and inserting ``ensure'';
and</DELETED>
<DELETED> (II) by striking ``; and''
and inserting a semicolon;</DELETED>
<DELETED> (v) by redesignating paragraph (6)
as paragraph (9);</DELETED>
<DELETED> (vi) by inserting after paragraph
(5), the following:</DELETED>
<DELETED> ``(6) to enhance appropriate support activities to
increase breast and cervical cancer screening such as patient
navigation, implementation of evidence-based or evidence-
informed strategies proven to increase breast and cervical
cancer screening in health care settings, and facilitating
access to health care settings;</DELETED>
<DELETED> ``(7) to reduce disparities in incidents of and
deaths due to breast and cervical cancer in populations with
higher than average rates;</DELETED>
<DELETED> ``(8) to ensure equitable access to screening and
diagnostic services and improve access for individuals who
encounter additional barriers to receiving services, including
due to various social determinants of health; and'';
and</DELETED>
<DELETED> (vii) in paragraph (9), as so
redesignated, by striking ``through (5)'' and
inserting ``through (8)''; and</DELETED>
<DELETED> (B) by striking subsection (d);</DELETED>
<DELETED> (2) in section 1503 (42 U.S.C. 300m)--</DELETED>
<DELETED> (A) in subsection (a)--</DELETED>
<DELETED> (i) in paragraph (1), by striking
``that, initially'' and all that follows
through the semicolon and inserting ``that
appropriate breast and cervical cancer
screening and diagnostic services are provided
based on national recommendations;
and'';</DELETED>
<DELETED> (ii) by striking paragraphs (2)
and (4);</DELETED>
<DELETED> (iii) by redesignating paragraph
(3) as paragraph (2); and</DELETED>
<DELETED> (iv) in paragraph (2), as so
redesignated, by striking ``; and'' and
inserting a period; and</DELETED>
<DELETED> (B) by striking subsection (d);</DELETED>
<DELETED> (3) in section 1508(b) (42 U.S.C. 300n-4(b))--
</DELETED>
<DELETED> (A) by striking ``1 year after the date of
the enactment of the National Breast and Cervical
Cancer Early Detection Program Reauthorization of 2007,
and annually thereafter,'' and inserting ``2 years
after the date of enactment of the Screening for
Communities to Receive Early and Equitable Needed
Services for Cancer Act of 2023, and every 5 years
thereafter,'';</DELETED>
<DELETED> (B) by striking ``Labor and Human
Resources'' and inserting ``Health, Education, Labor,
and Pensions''; and</DELETED>
<DELETED> (C) by striking ``preceding fiscal year''
and inserting ``preceding 2 fiscal years in the case of
the first report after the date of enactment of the
Screening for Communities to Receive Early and
Equitable Needed Services for Cancer Act of 2023 and
preceding 5 fiscal years for each report thereafter'';
and</DELETED>
<DELETED> (4) in section 1510(a) (42 U.S.C. 300n-5(a))--
</DELETED>
<DELETED> (A) by striking ``and'' after ``2011,'';
and</DELETED>
<DELETED> (B) by inserting ``, $275,000,000 for
fiscal year 2024, $330,000,000 for fiscal year 2025,
$385,000,000 for fiscal year 2026, $440,000,000 for
fiscal year 2027, and $500,000,000 for fiscal year
2028'' before the period at the end.</DELETED>
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Screening for Communities to Receive
Early and Equitable Needed Services for Cancer Act of 2023'' or the
``SCREENS for Cancer Act of 2023''.
SEC. 2. NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM.
Title XV of the Public Health Service Act (42 U.S.C. 300k et seq.)
is amended--
(1) in section 1501 (42 U.S.C. 300k)--
(A) in subsection (a)--
(i) in paragraph (2), by striking ``the
provision of appropriate follow-up services and
support services such as case management'' and
inserting ``that appropriate follow-up services
are provided'';
(ii) in paragraph (3), by striking
``programs for the detection and control'' and
inserting ``for the prevention, detection, and
control'';
(iii) in paragraph (4), by striking ``the
detection and control'' and inserting ``the
prevention, detection, and control'';
(iv) in paragraph (5)--
(I) by striking ``monitor'' and
inserting ``ensure''; and
(II) by striking ``; and'' and
inserting a semicolon;
(v) by redesignating paragraph (6) as
paragraph (9);
(vi) by inserting after paragraph (5) the
following:
``(6) to enhance appropriate support activities to increase
breast and cervical cancer screenings, such as navigation of
health care services, implementation of evidence-based or
evidence-informed strategies to increase breast and cervical
cancer screening in health care settings, and facilitation of
access to health care settings;
``(7) to reduce disparities in breast and cervical cancer
incidence, morbidity, and mortality, including in populations
with higher than average rates;
``(8) to improve access to breast and cervical cancer
screening and diagnostic services and reduce related barriers,
including factors that relate to negative health outcomes;
and''; and
(vii) in paragraph (9), as so redesignated,
by striking ``through (5)'' and inserting
``through (8)''; and
(B) by striking subsection (d);
(2) in section 1503 (42 U.S.C. 300m)--
(A) in subsection (a)--
(i) in paragraph (1), by striking ``that,
initially'' and all that follows through the
semicolon and inserting ``that appropriate
breast and cervical cancer screening and
diagnostic services are provided consistent
with relevant evidence-based recommendations;
and'';
(ii) by striking paragraphs (2) and (4);
(iii) by redesignating paragraph (3) as
paragraph (2); and
(iv) in paragraph (2), as so redesignated,
by striking ``; and'' and inserting a period;
and
(B) by striking subsection (d);
(3) in section 1508(b) (42 U.S.C. 300n-4(b))--
(A) by striking ``1 year after the date of the
enactment of the National Breast and Cervical Cancer
Early Detection Program Reauthorization of 2007, and
annually thereafter,'' and inserting ``2 years after
the date of enactment of the Screening for Communities
to Receive Early and Equitable Needed Services for
Cancer Act of 2023, and every 5 years thereafter,'';
(B) by striking ``Labor and Human Resources'' and
inserting ``Health, Education, Labor, and Pensions'';
and
(C) by striking ``preceding fiscal year'' and
inserting ``preceding 2 fiscal years in the case of the
first report after the date of enactment of the
Screening for Communities to Receive Early and
Equitable Needed Services for Cancer Act of 2023 and
preceding 5 fiscal years for each report thereafter'';
and
(4) in section 1510(a) (42 U.S.C. 300n-5(a))--
(A) by striking ``2011, and'' and inserting
``2011,''; and
(B) by inserting ``, and $275,000,000 for each of
fiscal years 2024 through 2028'' before the period at
the end.
SEC. 3. GAO STUDY.
Not later than September 30, 2027, the Comptroller General of the
United States shall report to the Committee on Health, Education,
Labor, and Pensions of the Senate and the Committee on Energy and
Commerce of the House of Representatives on the work of the National
Breast and Cervical Cancer Early Detection Program, including--
(1) an estimate of the number of individuals eligible for
services provided under such program;
(2) a summary of trends in the number of individuals served
through such program; and
(3) an assessment of any factors that may be driving the
trends identified under paragraph (2), including any barriers
to accessing breast and cervical cancer screenings provided by
such program.
Calendar No. 317
118th CONGRESS
2d Session
S. 1840
_______________________________________________________________________
A BILL
To amend the Public Health Service Act to reauthorize and improve the
National Breast and Cervical Cancer Early Detection Program for fiscal
years 2024 through 2028, and for other purposes.
_______________________________________________________________________
February 1, 2024
Reported with an amendment